Thermo Fisher Scientific Inc. Revenue 2007–2025
Thermo Fisher Scientific Inc. annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Thermo Fisher Scientific Inc. revenue for the quarter ending March 28, 2026 was 11.0 B, a 6.18% increase year-over-year.
- Thermo Fisher Scientific Inc. revenue for the twelve months ending March 28, 2026 was 43.3 B, a 3.06% increase year-over-year.
- Thermo Fisher Scientific Inc. annual revenue for 2025 was 44.6 B, a 3.91% increase from 2024.
- Thermo Fisher Scientific Inc. annual revenue for 2024 was 42.9 B, a 0.05% increase from 2023.
- Thermo Fisher Scientific Inc. annual revenue for 2023 was 42.9 B, a 4.58% decrease from 2022.
- Thermo Fisher Scientific Inc. annual revenue for 2022 was 44.9 B.
Thermo Fisher Scientific Inc. (TMO) — Frequently Asked Questions
Thermo Fisher Scientific Inc. (TMO) is a publicly traded US company in the Healthcare sector. It has a market capitalization of $177.52B. In fiscal 2025 it reported revenue of $44.56B and net income of $6.70B. Explore TMO's stock price, financial statements, earnings history, margins and key ratios below.
What is Thermo Fisher Scientific Inc.'s market cap?
Thermo Fisher Scientific Inc. (TMO) has a market capitalization of $177.52B.
What is the TMO stock price?
TMO trades at $469.63 (-0.67% on the day).
How much revenue does Thermo Fisher Scientific Inc. make?
Thermo Fisher Scientific Inc. reported revenue of $44.56B in fiscal 2025.
Is TMO profitable?
In fiscal 2025, Thermo Fisher Scientific Inc. reported net income of $6.70B.
What is TMO's P/E ratio?
Based on diluted EPS, TMO has a price-to-earnings (P/E) ratio of about 26.5.